Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein.
about
The transcription factor p53: not a repressor, solely an activatorFunctional Significance of Aurora Kinases-p53 Protein Family Interactions in CancerThe CHR site: definition and genome-wide identification of a cell cycle transcriptional elementThe p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genesHuman papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway.Multicilin drives centriole biogenesis via E2f proteinsRole of dual specificity tyrosine-phosphorylation-regulated kinase 1B (Dyrk1B) in S-phase entry of HPV E7 expressing cells from quiescenceIntegration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks.The DREAM complex in antitumor activity of imatinib mesylate in gastrointestinal stromal tumors.Polo-like kinases: structural variations lead to multiple functions.Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.Census and evaluation of p53 target genes.Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control.The human papillomavirus E7 oncoprotein as a regulator of transcription.p53 downregulates the Fanconi anaemia DNA repair pathway.NEK7 is required for G1 progression and procentriole formation.The DREAM complex through its subunit Lin37 cooperates with Rb to initiate quiescence.Timing of transcription during the cell cycle: Protein complexes binding to E2F, E2F/CLE, CDE/CHR, or CHR promoter elements define early and late cell cycle gene expression.Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM.PLK4: a link between centriole biogenesis and cancer.Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes.p53 gain-of-function mutations increase Cdc7-dependent replication initiation.A novel role for Plk4 in regulating cell spreading and motility.
P2860
Q24273295-1A958129-0E6D-4607-8DCE-B403D0CEAA96Q28071615-E54ED551-AD61-43C7-804B-6309F1D79C2CQ28245565-B85CEFDE-A717-4DC2-A3F9-11B6DBC77272Q28267558-A694AD35-A969-4CB5-BEBB-84B2606C69EBQ33752967-CBAE7ECD-9BB4-4867-97C0-F7027EC215B6Q33850562-427584BD-0B50-405B-A66E-7569B0FC810BQ36544412-CC11C4BD-DFE9-4D47-B77C-D179838E90F4Q37197461-B397A226-FADD-4EE4-AF19-97BA7A97E391Q38212772-3FD64D82-10C7-445F-9C2E-73862F09213EQ38222354-C106F875-6404-41C4-B6AE-E896B9B7868EQ38310745-81CEE357-C680-4C58-9D46-EC7295633EE2Q38911126-81E605CA-FD1D-4E6C-BF9E-0C7DA67870B6Q38923325-6E0C7D9F-D1B7-44ED-A7D4-892B1C6A42E4Q39000409-8BED67E1-B222-43F2-86EA-572F90E87629Q39897828-29C3151E-84A4-4B88-909D-CEC6E67A3385Q41662062-40A15E96-9385-4272-A1A1-800621527E75Q41720368-BAEC9391-7AB6-449D-9197-42372C840490Q47112944-3D94D199-04D5-416F-8DEB-0D545ECAE4F6Q47232697-BFC49967-232E-4685-AF03-9D03EC6B3015Q47368506-061A0B14-4118-4A12-8F9D-0C2E6C4315C4Q47965098-995592AF-AFBA-4318-9A5E-06C46D694F2CQ48100871-3450B37D-13B4-48E0-A1D9-0C5810499E61Q55071514-07D958D8-231F-48B3-A698-515D80B76542
P2860
Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Polo-like kinase 4 transcripti ...... deregulated by HPV E7 protein.
@en
Polo-like kinase 4 transcripti ...... deregulated by HPV E7 protein.
@nl
type
label
Polo-like kinase 4 transcripti ...... deregulated by HPV E7 protein.
@en
Polo-like kinase 4 transcripti ...... deregulated by HPV E7 protein.
@nl
prefLabel
Polo-like kinase 4 transcripti ...... deregulated by HPV E7 protein.
@en
Polo-like kinase 4 transcripti ...... deregulated by HPV E7 protein.
@nl
P2860
P50
P356
P1476
Polo-like kinase 4 transcripti ...... deregulated by HPV E7 protein
@en
P2093
Axel Wintsche
Marianne Quaas
P2860
P304
P356
10.1093/NAR/GKT849
P407
P577
2013-09-25T00:00:00Z